BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
SNBTS are under contract with RTx to manufacture the RTX001 product throughout 2025. RTx have transferred their manufacturing procedure to SNBTS and SNBTS are required to use the reagents/consumables specified by RTx within that process.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Bio-Techne | 02490104 | - | 1 lot Cytokines | - |
| Life Technologies | SC083107 | - | 1 lot Rotea kits | - |
| Lonza | - | - | 1 lot P3 buffer and nucleofector consumables | - |
| Miltenyi Biotec Ltd. | 03096272 | - | 1 lot Prodigy cell processor | - |
This procurement was divided into 4 lots, each awarded separately. 8 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Cytokines | £1,018,000 initial term | 1 single bid — no competition | Bio-Techne | active |
| Lot 2 P3 buffer and nucleofector consumables | £412,000 initial term | 1 single bid — no competition | Lonza | active |
| Lot 3 Prodigy cell processor | £1,262,000 initial term | 1 single bid — no competition | Miltenyi Biotec Ltd. | active |
| Lot 4 Rotea kits | £110,600 initial term | 1 single bid — no competition | Life Technologies | active |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £1,065,558,019 in 3,704 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, Police Scotland, Manchester University NHS Foundation Trust, DEFRA and 9 more public bodies (2016-07-25 to 2026-03-31).